After its authorization by American health authorities last year, Valneva France recently announced that its vaccine single dose against chikungunya is available in France, on compulsory medical prescription.
The first vaccine against chikungunya
After the green light from the European Union last July, the French company Valneva announced on November 20, 2024, the marketing of its vaccine against this disease transmitted to humans by infected mosquitoes (we speak of zoonosis). Administered in a single dose, the vaccine uses the live attenuated virus technique, that is to say that it is made up of living germs (viruses, bacteria) which have been modified so that they lose their infectious power but retain their capacity to create protection in the vaccinated person.
It is indicated in adults only more contraindicated in immunocompromised people.
Chikungunya: a disease transmitted by Aedes mosquitoes
Chikungunya, which means “who walks bent forward” in Makondé (a southern African language), is characterized by the sudden appearance of fever and of joint painsevereparticularly on the wrists, ankles, feet, knees and sometimes hips and shoulders… The virus can also cause nausea,…
Read more
Health
